Abbott Laboratories

Baby formula shortage could ease as Abbott reopens Michigan plant

The company said it will begin production of EleCare and other specialty and metabolic formulas, with initial EleCare product release to consumers beginning on or about June 20

Piramal Enterprises board approves to demerge and list pharma business

The demerger will give potential investors the option of being associated with the business of their choice

Abbott introduces single-dose formulation of carbetocin in India

Drug major Abbott on Tuesday said it has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH)

Abbott profit more than doubles as medical device sales rebound

(Reuters) -Abbott Laboratories' quarterly profit more than doubled on Thursday, due to strength in its diagnostics business and a rebound in medical device sales.

Piramal Pharma readies war chest for potential acquisition targets

A decade after Piramal sold its domestic formulations business to Abbott Laboratories for $3.72 billion, the group is now looking at re-entering the space in India

Test that can detect coronavirus in 5 minutes; courtesy Abbott Labs

Abbott to supply 50,000 tests a day starting April 1

Abbott India Q2 net up 30% at Rs 178 crore, total income rises 8%

The company had posted a profit of Rs 137.68 crore for the year-ago period, Abbott India said in a filing to BSE

Survivor tales to drive healthy living

Abbott's campaign uses real-life stories to convey its promise of creating breakthrough products

Drug maker Abbott to reimburse stockists for GST losses

Drug maker Abbott will reimburse its trade partners for losses which could arise due to changes in the tax rate with the implementation of Goods and Service Tax from July 1.The move follows reports that stockists and distributors are keeping inventories to minimum and there are fears this could result in shortage of medicines in the market.In a note to its trade partners on Wednesday, Abbott said in case the new tax structure and the input claim process results into any loss to partner stockists on the closing inventory on June 30 or day preceding GST implementation, it will reimburse such value to the stockist. " This will ensure that our partner stockists do not suffer any loss resulting from tax structure changes on the inventory they hold," Abbott said. The company also requested its distributors to maintain normal inventory and ensure adequate availability of drugs during transition phase.GST will come into effect from July 1 and its implementation will change tax rate and ...

Abbott Laboratories agrees to buy Alere at lower price from earlier offer

Abbott will now pay $51 per share for Alere, compared with its earlier offer of $56 per share